A new study uncovered yet another risk to unborn babies, joining a list of common treatments and practices that can lead to neurological issues for children.
A recent study suggests that prenatal exposure to anti-seizure medications may increase the risk of child neurodevelopmental disorders. The peer-reviewed paper was published in the journal JAMA Neurology on May 31.
A team of 17 scientists, most of whom are from Scandinavia, studied more than 4.5 million babies who were exposed to various anti-seizure medicines that their mothers were taking while the babies were in utero.
The scientists analyzed the effects of several anti-seizure drugs, including topiramate and valproate, as well as prenatal exposure to combinations of anti-seizure medicines, such as taking levetiracetam with carbamazepine and taking lamotrigine with topiramate….